After hours: March 20 at 4:05:12 PM EDT Loading Chart for HBB ...
Improve RBC quality and production Luspatercept BMS FDA approved for TD β-thalassemia and MDS-RS Cappellini et al., 2023 Mitapivat Agios FDA approved for PKD; in phase II clinical trial for NTD α- and ...
After hours: March 21 at 5:41:06 p.m. EDT Loading Chart for HBB ...
Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world ...
After hours: March 21 at 6:20:36 PM EDT Loading Chart for DTIL ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results